Kukjeon Pharmaceutical Co Ltd
KOSDAQ:307750
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| KR |
K
|
Kukjeon Pharmaceutical Co Ltd
KOSDAQ:307750
|
152.9B KRW |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
986.4B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
586.1B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
286.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
235.3B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
239B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
301.2B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157.3B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.4B USD |
Loading...
|
Market Distribution
| Min | -646.5% |
| 30th Percentile | 12.8% |
| Median | 19.7% |
| 70th Percentile | 32.2% |
| Max | 54 001.3% |
Other Profitability Ratios
Kukjeon Pharmaceutical Co Ltd
Glance View
Kukjeon Pharmaceutical Co., Ltd. engages in providing financial support services. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2018-12-19. The firm manufactures and sells raw materials used in specialized medicines such as choline alfoscerates, benfothiamines, spherical sorbents, and napamostat mesylatse. The firm sells its products in domestic and overseas markets such as Japan.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Kukjeon Pharmaceutical Co Ltd is 13.6%, which is below its 3-year median of 17.7%.
Over the last 3 years, Kukjeon Pharmaceutical Co Ltd’s Gross Margin has decreased from 18.7% to 13.6%. During this period, it reached a low of 13.6% on Oct 30, 2025 and a high of 22% on Sep 30, 2023.
